Canada: Canada's New "Just Say Slow" Takeover Bid Regime

The Canadian Securities Administrators (CSA) have released today draft rules on Canada's new "just say slow" takeover bid regime. Under this new regime, the minimum period during which a takeover bid must remain open is extended to 120 days (subject to a target board's ability to shorten the timeframe to as little as 35 days in certain cases). The rules preserve the right of shareholders to respond to a bid, but on a collective basis, by mandating a new 50% minimum tender condition. Once the minimum tender condition has been met, undecided shareholders will benefit from an additional 10-day extension to accept the outstanding bid.

The new rules will reshape the current takeover bid regime by redefining bid dynamics between target boards and hostile bidders. The new 120-day period will provide boards with more time to "just say slow" and evaluate a hostile bid, seek value-enhancing alternatives or convince shareholders to stay the course and reject the bid. As a result, boards will wield more negotiating leverage which will likely encourage a bidder's engagement with the target.


The CSA's draft rules mark the end of a two-year regulatory process, which commenced with parallel proposals by the CSA and Québec securities regulator (AMF) on reform of the regulation of defensive measures. While the AMF had broad ambitions to revamp Canada's defensive tactics policy entirely to give target boards discretion to defend against and reject hostile bids, the CSA's proposal focused on their right to maintain a poison pill for 90 days, subject to shareholder approval. Details of the earlier CSA and AMF proposals are set out in our bulletin " Canadian Companies Will be Harder to Acquire Under New Poison Pill Proposals."

Subsequently setting aside their competing initiatives, regulators endorsed a compromise solution aimed at the takeover bid rules themselves, rebalancing bid dynamics between target boards and hostile bidders. The new proposal, for which they have now released draft rules, effectively codifies existing "permitted bid" terms commonly found in most poison pills (although the minimum bid period will be 120 days rather than the customary 60 days).

New CSA Draft Rules

Key aspects of the CSA's new rules are set out below:

  • New takeover bid framework. All non-exempt takeover bids will need to meet the following three requirements: (i) a mandatory minimum tender condition of over 50% of outstanding shares, other than shares held by the bidder and its joint actors; (ii) a 10-day extension once the 50% minimum tender threshold has been met and the bidder announces its intention to immediately take up and pay for deposited securities; and (iii) a 120-day minimum bid period, which can be shortened in certain cases. The existing takeover bid exemptions will remain unchanged under the new regime.
  • 120-day period waivable to 35 days. The rules provide that target boards may shorten the 120-day minimum bid period to as little as 35 days by issuing a news release to that effect. The 120-day minimum bid period will also be shortened to 35 days (calculated from the date of the bid) if the target company issues a press release announcing that it has agreed to enter into, or determined to effect, a specified alternative transaction, such as a plan of arrangement. In circumstances where the minimum bid period has been shortened from 120 days, the shorter period will apply to any other competing bids.
  • Partial bids allowed. The rules do not prohibit partial bids from being made so long as the 50% minimum tender condition is met and there is an automatic 10-day extension (further extensions of a partial bid beyond the first 10-day extension will not be permitted). Mechanics addressing pro-ration issues and withdrawal rights are also incorporated in the rules.
  • Extension of bid period for notices of change or variation.If a bidder needs to send a notice of change prior to the expiry of the initial deposit period, the draft rules provide that the deposit period must not expire before 10 days after the date of the notice of change, which means the deposit period may need to be extended by the bidder. Similarly, where the 120-day minimum tender period is reduced in any of the circumstances described above after a bidder has launched its bid, the bidder will need to send a notice of variation to take advantage of the shortened period, but will need to ensure that the bid does not expire before 10 days from the notice of variation.
  • Timing of directors' circular. At the moment, the rules do not propose any change to the existing requirement that the directors' circular evaluating the bid and advising target shareholders must be sent within 15 days of the bid. However, the CSA are seeking feedback as to whether this current time limit is sufficient.

120 Days: New Focus for Hostile Bidders

Directors of a Canadian target company facing a hostile bid currently must decide how to respond to the bid within a tight statutory timeframe: the directors' circular evaluating the bid and advising target shareholders must be sent within 15 days of the bid; and the bid may expire in as few as 35 days. Boards often take defensive measures, such as the implementation of a poison pill, with a view to buying more time to seek an alternative offer or creating leverage to negotiate an improved offer. In light of the regulatory treatment of poison pills, a hostile bidder is typically able to obtain an order from the regulator to cease trade the pill within approximately 45 to 60 days. Given this current framework, hostile bidders have found it relatively easy to bypass a target board and launch a bid directly to shareholders.

The new 120-day period will increase deal uncertainty for hostile bidders, exposing them, for example, to interloper risk for a much longer period of time. As a result, the extended timeframe will strengthen target boards' negotiating leverage. We anticipate that hostile bidders will perceive the benefit of engaging more with target boards who will have the ability to waive the minimum tender period for friendly transactions. While the new bid framework will also provide more breathing room for boards and certainty around the time that boards have to respond to a hostile bid, it will continue to leave shareholders with the final say on whether a bid should be accepted.

Poison Pills Will Still Have Use

CSA National Policy 62-202 governing defensive tactics remains unchanged by the new rules. Target boards will continue to see the benefit of adopting a poison pill in order to regulate exempt purchases of target securities through creeping acquisitions and private agreement purchases, and prevent irrevocable lock-up agreements.

However, we would expect that the regulators would not generally permit a target board to maintain a poison pill if a bid has been accepted by a majority of disinterested shareholders and if the bid otherwise complies with the new rules.

Next Steps

The draft rules are open for comment until June 29, 2015.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.